Brian Robert Champion
23Patents
4h-index
27Co-inventors
59Inventor score
Filing activity: Dec 9, 2009 → Dec 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10034905B2 | Group B adenovirus modified in the E4orf4 region | Chemistry; Metallurgy | 7 | Active |
| US9216229B2 | IgE CH3 peptide vaccine | Human Necessities | 7 | Active |
| US9987314B2 | Oncolytic adenoviruses armed with heterologous genes | Chemistry; Metallurgy | 6 | Active |
| US8889144B2 | PCSK9 vaccine | Chemistry; Metallurgy | 5 | Active |
| US8298547B2 | IgE CH3 peptide vaccine | Human Necessities | 4 | Active |
| US8722053B2 | IgE CH3 peptide vaccine | Emerging Cross-Sectional Technologies | 3 | Active |
| US10548929B2 | Oncolytic adenovirus encoding a therapeutic protein or active fragment | Chemistry; Metallurgy | 3 | Active |
| US10849945B2 | Oncolytic adenovirus encoding a B7 protein or active fragment | Chemistry; Metallurgy | 2 | Active |
| US11155622B2 | Virus encoding an anti-TCR-complex antibody or fragment | Chemistry; Metallurgy | 2 | Active |
| US11000559B2 | Oncolytic adenovirus encoding a B7 protein | Chemistry; Metallurgy | 1 | Active |
| US11439678B2 | Oncolytic adenoviruses armed with heterologous genes | Chemistry; Metallurgy | 1 | Active |
| US8475801B2 | IgE CH3 peptide vaccine | Human Necessities | 1 | Active |
| US9987341B2 | PCSK9 vaccine | Chemistry; Metallurgy | 0 | Active |
| US12258417B2 | Adenovirus armed with bispecific T cell engager | Chemistry; Metallurgy | 0 | Active |
| US9481875B2 | PCSK9 vaccine | Chemistry; Metallurgy | 0 | Active |
| US11938159B2 | Oncolytic adenoviruses armed with heterologous genes | Chemistry; Metallurgy | 0 | Active |
| US11142580B2 | Oncolytic virus and method | Emerging Cross-Sectional Technologies | 0 | Active |
| US10124028B2 | Oncolytic adenovirus encoding a B7 protein or active fragment | Chemistry; Metallurgy | 0 | Active |
| US10322152B2 | Oncolytic adenovirus encoding a B7 protein | Chemistry; Metallurgy | 0 | Active |
| US12049513B2 | Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell engager | Chemistry; Metallurgy | 0 | Active |
| US11840702B2 | Adenovirus armed with bispecific T cell activator | Chemistry; Metallurgy | 0 | Active |
| US9249233B2 | IgE CH3 peptide vaccine | Emerging Cross-Sectional Technologies | 0 | Active |
| US11970536B2 | Group B adenovirus encoding an anti-TCR-complex antibody or fragment | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.